Man Group’s Wave Life Sciences WVE Stock Holding History

Man Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Buy	505,456 +441,420	+689%	+$2.93M	﹤0.01%	1390
2026 Q1	$464K	Buy	64,036 +32,618	+104%	+$425K	﹤0.01%	2107
2025 Q4	$534K	Sell	31,418 -101,353	-76%	-$1.03M	﹤0.01%	1880
2025 Q3	$972K	Buy	132,771 +73,492	+124%	+$595K	﹤0.01%	1683
2025 Q2	$385K	Buy	+59,279	New	+$391K	﹤0.01%	1908
2023 Q1	–	Sell	-17,842	Closed	-$81.8K	–	1888
2022 Q4	$125K	Buy	+17,842	New	+$82.2K	﹤0.01%	1876
2021 Q2	–	Sell	-11,415	Closed	-$64K	–	2111
2021 Q1	$64K	Sell	11,415 -75,700	-87%	-$727K	﹤0.01%	1816
2020 Q4	$686K	Buy	+87,115	New	+$731K	﹤0.01%	1487
2018 Q4	–	Sell	-5,748	Closed	-$287K	–	2139
2018 Q3	$287K	Buy	+5,748	New	+$259K	﹤0.01%	1967
2018 Q2	–	Sell	-5,458	Closed	-$219K	–	2247
2018 Q1	$219K	Buy	+5,458	New	+$229K	﹤0.01%	1908

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Man Group's WVE Position: Q2 2026 in Review

Man Group increased its Wave Life Sciences (WVE) stake by 689% in Q2 2026, buying an estimated $2.93M and bringing the position to 505,456 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Man Group first reported a position in WVE in Q1 2018 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Man Group held 505,456 shares of Wave Life Sciences worth $2.94M as of Q2 2026.
Man Group bought 441,420 Wave Life Sciences shares in Q2 2026, an estimated $2.93M.
Wave Life Sciences made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1390 holding.
Man Group first reported a position in Wave Life Sciences in Q1 2018 and has held it in 10 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.